Tag Archives: strain

The Covid-19 Variant That Devastated In Brazil Is Now The Most Reported Variant In The US, CDC Data Show | Instant News

Top line

The P.1 variant of the coronavirus that helped drive a devastating wave of infections in Brazil is now the second most reported variant in the US, data from the Centers for Disease Control and Prevention (CDC) show, following an increase in new infections and the spread of the B.1.1 virus. 7 British variants that are contagious are now the dominant strains circulating in the US.

Key facts

Variant P.1, which has grown rapidly in Brazil, think being more contagious than the original strain of Covid-19 and potentially evading an immune response, had been detected in 28 states as of April 8, CDC data show.

434 cases involving the variant have been reported, making it the second most frequently reported variant for the first time.

Most of the cases were reported in Illinois (93), Florida (87) and Massachusetts (102).

P.1 is by far the second most widely reported variant – the B.1.1.7 virus first identified in the UK – which the CDC says is now dominant variant circulating in the US, recorded nearly 20,000 times in all 50 states.

Key Background

Brazil is facing a Covid-19 crisis so bad that only one expert be equalized it’s for a nuclear reaction out of control. The country has the second number of deaths after the US and daily deaths rose to over 4,000 a day this week. While multiple variants have been detected in Brazil, officials in the US and UK believe P.1 is a very concern, most likely more contagious and better able to evade the body’s defenses. It has spread rapidly, helped by President Jair Bolsonaro’s continued refusal to put in place lockdown measures to contain the outbreak.

Big Numbers

345,000. This is the number of people in Brazil who have died from Covid-19 since the pandemic began, according to data from Johns Hopkins University. It is the second highest death toll in the world after the United States, where more than 560,000 people have died.

Further reading

Brazilian Covid Variant: What do we know about P1? (Guardian)

Covid: Brazil had more than 4,000 deaths in 24 hours for the first time (BBC)

The British Coronavirus Variant Is Now The Dominant Strain In The US, The CDC Says (Forbes)

Researchers Says The British Covid-19 Variant That Spreads Fast Up To Twice More Deadly Than Others (Forbes)

Full coverage and live updates about Coronavirus


image source

The ties between Nawaz, Zardari grew tense | Instant News

ISLAMABAD: Working relations between the top leaders of the Pakistan Muslim League (PML-N) and the PPP have become increasingly strained as former PML-N prime minister Quaid Nawaz Sharif refused to speak to Asif Ali Zardari after the loud speech. the last was in the closed meeting of the PDM party chairman last week.

PDM Chairman Maulana Fazlur Rehman tried hard to criticize the two. He spoke to the two separately the following day of an alliance meeting at which Zardari refused to hand over his resignation from the joint assembly by marching against the government.

Political sources told The News here Sunday that the only contention between the PML-N and the PPP is to resign from the assembly and sit down after the long march. Recent events have also helped deteriorate relations between the two parties. The candidacy of the opposition leader in the Senate and support for the PML-N candidate in the chair Karachi NA-249 where PML-N has fielded Miftah Ismail as its candidate based on prior understanding between PDM member parties.

The PPP also appointed its candidates in the contest against understanding. Former PML-N prime minister and senior vice president Shahid Khaqan Abbasi visited Zardari House on Saturday to gather PPP support for Miftah and meet PPP Chairman Bilawal Bhutto Zardari.

The source said that the PPP leader made no guarantees to the visiting PML-N leader for the vote in Karachi. Instead, he put it off on the pretext of consulting the party before making any decisions. The source said that Shahid Khaqan Abbasi had reported the matter to Quaid Nawaz Sharif and asked for his guidance in this matter.

PDM head Maulana Fazl announced on Sunday that alliance workers will accompany Maryam Nawaz Sharif on Friday when she will appear in front of the NAB regional office in Lahore. Since the announcement came from the platform PDM and PPP are still a part of it. PPP has serious complaints about NAB and takes offense about the implementation of NAB. It is not clear whether the PPP workers and leaders will convey solidarity with Maryam Nawaz Sharif on this occasion.

Maulana Fazl will speak with the PPP leadership about the issue as she understands that the strong participation of PPP workers in groups with Ms Maryam’s convoy will help resolve tensions between the two parties. Sources suggest that Maulana Fazl could dash to Karachi to meet with PPP leaders this week as long as he gets a positive signal from there. He will make other efforts to restore mutual trust between PML-N and PPP supporters. He will try to hold a trilateral conference with Nawaz Sharif and Asif Ali Zardari while in Karachi, the sources added.


image source

Australian Coronavirus News: Health Minister Greg Hunt provides the latest information on COVID vaccination efforts | Instant News

Doctors are preparing to be part of a nationwide COVID-19 vaccination program

The Federal Government and the country’s top medical groups say there are 4,500 doctors across the country preparing to be part of the COVID-19 vaccination program.

More than 1,000 doctors will start administering the vaccine from March 22, with many more due to join the program in the weeks following.

The rollout of the COVID-19 vaccination program kicked off at hospitals and elderly care centers across the country, and Health Minister Greg Hunt said the expansion to doctors would help more Australians access the injections in the coming months.

Australian Medical Association Vice President Dr Chris Moy spoke to ABC News Breakfast to discuss the launch:

ABC News

“So, starting from about two weeks, we’ll be at the starting line where about 4,500 practices have, in fact, been approved in the first phase. And during the first four weeks or so it will be staged until launch. Initially, given a relatively small number, because it’s not like the flu vaccine where we have 20 million shots ready to go. “

“They will be given a limited supply at an early stage to start vaccination and start their clinic and to start a vaccination program.”


image source

Three people tested positive for the British variant of COVID-19 at Davidson College | Instant News

“Our contact tracing and quarantine have worked effectively, and many of our positive test results have come from students who have been quarantined from across campus,” read a statement from the school. “However, as you will read below, the variants – of which there are at least four concerns – will continue to reach the campus. Although the virus is slightly different, the ways to prevent it are the same: a mask, 6 feet distance, and washing your hands. “


image source

Australians ‘can still believe’ in the COVID-19 vaccine despite the South African, British strains | Instant News

Health experts say Australians can still have confidence in the country’s vaccine strategy, even though the two highly contagious strains of the coronavirus continue to spread rapidly around the world.

Corona virus type B.1.351, often referred to as the South African variant, has been detected in 41 countries (including Belgium, Netherlands and Mozambique) and believed 50 percent more infectious than the existing strains.

The B.1.1.7 variant comes from England and has been detected in 80 countries (including Denmark, Israel, and the US), and maybe 36 to 71 percent more can be transmitted.

Chief Medical Officer Professor Paul Kelly has warned of two variants – which one more contagious and can lead to more severe cases of disease – is on his way to be the dominant strain of COVID-19 worldwide.

This is a problem health authorities in Victoria are soon facing, with at least six of the 11 cases linked to the Holiday Inn cluster in Melbourne confirmed as a British variant, with another five being investigated.

La Trobe University Associate Professor in Epidemiology Hassan Vally said the two new strains “outperformed” the original virus.

It’s becoming the dominant strain because it spreads faster, he said.

Dr Vally said the longer the new variants were around and transferred from person to person, the greater their chance of mutating further and creating new strains that were potentially more contagious.

“We’re going to be in a situation where if we don’t eradicate it, and it continues for a while and we don’t control the transmission, it creates more opportunities for further mutations,” he said.

The University of Queensland professor of medicine, Paul Griffin, agrees.

“With a common virus like this, mutations cannot be avoided,” he said.

Space to play or pause, M to mute, left and right arrows to search, up and down arrows for volume.

The Chief Medical Officer said the South African variant became a ‘normal strain’ of the coronavirus globally

Pfizer, AstraZeneca and new variants

The Australian Government has secured approximately 20 million doses of Pfizer vaccine and 53.8 million doses of AstraZeneca options.

Later this month, the Federal Government will launch Pfizer stabs into Australia from the priority group, a group that includes elderly care workers and residents.

One small laboratory study suggested the Pfizer vaccine would be effective against the UK and South African variants, but Professor Vally urged caution when interpreting the findings because they were preliminary and from a small number of participants.

“This is a small in-vitro [in the test tube] a study in which serum panels of 20 participants who had previously been immunized with the Pfizer-BioNTech vaccine were tested in the laboratory for activity against non-mutant viral strains as well as engineered mutant viruses, “he said.

Most Australians will get the AstraZeneca COVID-19 shot, which is the vaccine South Africa recently halted launches in the midst of worry it offers only limited protection against minor ailments of the B.1.351 strain.

The South African decision came after a small-scale local release a study of 2,000 people who discovered the AstraZeneca vaccine offers a minimum of 10 percent protection against mild to moderate ailments caused by the B1351 variant.

Dr Vally said the decision South Africa made “made a lot of sense” because this specific strain had more than 90 percent of cases are genetically sequenced in South Africa and its populations need to be protected from this variant.

The company behind the AstraZeneca jab says it still can protects from severe disease, and Dr Vally is supporting the vaccine rollout in Australia

“The data we have is a very small study, the scope is limited,” he said.

“We have to be careful about how we interpret these findings and not go overboard.

“The most important thing is that it is safe and effective against severe disease.”

Two test staff in protective gear lowered the COVID-19 swabs into bags labeled biological hazards.
As of February 5, 18 cases of variant B1351 have been confirmed in Australia.(ABC News: Hugh Sando)

Professor Paul Griffin said he would “definitely not ignore” AstraZeneca based on the research and he still believes in Australia’s vaccine plan.

“It is thought to be reasonable that this vaccine could still have a meaningful impact in preventing hospitalizations and deaths from this strain, which is obviously still very important,” he said.

It should also be noted that preliminary results show AstraZeneca performed quite well against the British variant.

And it’s not only AstraZeneca that has been less effective against the South African variant; everything is less effective, including files Novavax Vaccine.

Do we need a COVID-19 booster shot?

Potentially, but it’s too early to know for sure.

Professor Griffin said even if COVID-19 vaccine manufacturers needed to update their vaccines to tackle a new strain, it wouldn’t be a long process – but a process that could reverse in weeks or months.

“This is really a very simple update.”

The World Health Organization says producers “must be prepared to adapt to the evolution of the SARS-CoV-2 virus, including the possibility of providing future booster shots and an adapted vaccine, if scientifically deemed necessary ”.

Pfizer said earlier it could develop a freshly adapted vaccine in a few weeks.

Dr Vally said the current vaccine was most likely the “first generation” of the COVID-19 vaccine.

“We will just keep updating our vaccine,” he said.

How do manufacturers update vaccines?

Professor Raina MacIntyre, head of the biosecurity program at the Kirby Institute at the University of New South Wales, said a meaningful update was needed to adapt the jab to suit mutations in the new strain.

“All vaccines target a specific protein on the surface of the virus,” he said.

“If the protein changes through mutation, the vaccine also needs to be adjusted to match the mutation.

“It’s easy, but faster for mRNA vaccines than traditional vaccines.”

Should we change our vaccine strategy?

As of February 5, Australia has recorded 87 cases of the British strain and 18 of the South African variant – Small amount compared to caseload abroad.

Professor Griffin said he believed it was too early for Australia to change its position regarding one of its vaccine candidates.

“If our TGA approves a vaccine, we can be very confident in its use.”

Dr Vally said while vaccination is one way to stop transmission of the virus, it is not the only tool in the toolbox.

“Obviously any new variant will be a challenge for us, but if you don’t have viral transmission, no matter what dominant strain if we control transmission using other tools at our disposal … vaccination is one of those tools,” he said.


image source